Yiwen Bu

942 total citations
17 papers, 759 citations indexed

About

Yiwen Bu is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Yiwen Bu has authored 17 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cell Biology and 6 papers in Cancer Research. Recurrent topics in Yiwen Bu's work include Aldose Reductase and Taurine (6 papers), Cancer-related Molecular Pathways (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Yiwen Bu is often cited by papers focused on Aldose Reductase and Taurine (6 papers), Cancer-related Molecular Pathways (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Yiwen Bu collaborates with scholars based in United States, China and Iraq. Yiwen Bu's co-authors include J. Alan Diehl, Deliang Cao, Chenfei Huang, Jun Ma, Yi Shen, Serge Y. Fuchs, Nilesh Chitnis, Constantinos Koumenis, Yingchun He and Yu Cao and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature Cell Biology.

In The Last Decade

Yiwen Bu

16 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiwen Bu United States 16 433 276 218 105 83 17 759
Mariana Cooke United States 19 581 1.3× 113 0.4× 152 0.7× 163 1.6× 46 0.6× 37 942
Zheng Jiang China 19 527 1.2× 210 0.8× 211 1.0× 111 1.1× 171 2.1× 36 974
George Talbott United States 9 792 1.8× 186 0.7× 90 0.4× 93 0.9× 192 2.3× 17 1.1k
Ya‐Ju Hsieh Taiwan 14 509 1.2× 103 0.4× 237 1.1× 59 0.6× 47 0.6× 29 876
Connie W. Lam United Kingdom 13 521 1.2× 241 0.9× 119 0.5× 222 2.1× 88 1.1× 15 956
Eun Ji Lee South Korea 15 552 1.3× 93 0.3× 293 1.3× 85 0.8× 76 0.9× 30 870
Deborah Brancho United States 7 530 1.2× 104 0.4× 127 0.6× 85 0.8× 45 0.5× 7 695
Cunxi Li United States 17 851 2.0× 151 0.5× 186 0.9× 81 0.8× 35 0.4× 29 1.1k
M. Gloria Luciani United Kingdom 15 812 1.9× 187 0.7× 163 0.7× 80 0.8× 61 0.7× 18 1.2k
Huafei Zou United States 17 489 1.1× 144 0.5× 84 0.4× 56 0.5× 46 0.6× 25 774

Countries citing papers authored by Yiwen Bu

Since Specialization
Citations

This map shows the geographic impact of Yiwen Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiwen Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiwen Bu more than expected).

Fields of papers citing papers by Yiwen Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiwen Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiwen Bu. The network helps show where Yiwen Bu may publish in the future.

Co-authorship network of co-authors of Yiwen Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Yiwen Bu. A scholar is included among the top collaborators of Yiwen Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiwen Bu. Yiwen Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Xu, Weiling, Yiwen Bu, Min Zeng, et al.. (2025). Clinical Outcome of Extramedullary Multiple Myeloma in the Era of Novel Agents: Insights From a Multicenter Study. Hematological Oncology. 43(4). e70112–e70112.
2.
Yoshida, Akihiro, Yiwen Bu, Shuo Qie, et al.. (2019). SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors. Science Advances. 5(9). eaax6352–eaax6352. 34 indexed citations
3.
Huang, Chenfei, Zhe Cao, Jun Ma, et al.. (2018). AKR1B10 activates diacylglycerol (DAG) second messenger in breast cancer cells. Molecular Carcinogenesis. 57(10). 1300–1310. 33 indexed citations
4.
Cao, Yu, Yiwen Bu, Hongyan Ling, et al.. (2017). p53-inducible long non-coding RNA PICART1 mediates cancer cell proliferation and migration. International Journal of Oncology. 50(5). 1671–1682. 30 indexed citations
5.
Bu, Yiwen, Akihiro Yoshida, Nilesh Chitnis, et al.. (2017). A PERK–miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival. Nature Cell Biology. 20(1). 104–115. 82 indexed citations
6.
Bu, Yiwen, Guoshuai Cai, Yi Shen, et al.. (2016). Targeting NF-κB RelA/p65 phosphorylation overcomes RITA resistance. Cancer Letters. 383(2). 261–271. 22 indexed citations
7.
Xu, Zhenhua, Yiwen Bu, Nilesh Chitnis, et al.. (2016). miR-216b regulation of c-Jun mediates GADD153/CHOP-dependent apoptosis. Nature Communications. 7(1). 11422–11422. 72 indexed citations
8.
Bu, Yiwen & J. Alan Diehl. (2016). PERK Integrates Oncogenic Signaling and Cell Survival During Cancer Development. Journal of Cellular Physiology. 231(10). 2088–2096. 61 indexed citations
9.
Huang, Chenfei, Steven J. Verhulst, Yi Shen, et al.. (2016). AKR1B10 promotes breast cancer metastasis through integrin α5/δ-catenin mediated FAK/Src/Rac1 signaling pathway. Oncotarget. 7(28). 43779–43791. 29 indexed citations
10.
Bu, Yiwen, Xiaoning Li, Yingchun He, et al.. (2015). A phosphomimetic mutant of RelA/p65 at Ser536 induces apoptosis and senescence: An implication for tumor‐suppressive role of Ser536 phosphorylation. International Journal of Cancer. 138(5). 1186–1198. 32 indexed citations
11.
Shen, Yi, Jun Ma, Ruilan Yan, et al.. (2014). Impaired Self-Renewal and Increased Colitis and Dysplastic Lesions in Colonic Mucosa of AKR1B8-Deficient Mice. Clinical Cancer Research. 21(6). 1466–1476. 49 indexed citations
13.
Luo, Dixian, Yiwen Bu, Jun Ma, et al.. (2013). Heat Shock Protein 90-α Mediates Aldo-Keto Reductase 1B10 (AKR1B10) Protein Secretion through Secretory Lysosomes. Journal of Biological Chemistry. 288(51). 36733–36740. 22 indexed citations
14.
Ma, Jun, Dixian Luo, Chenfei Huang, et al.. (2012). AKR1B10 overexpression in breast cancer: Association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker. International Journal of Cancer. 131(6). E862–71. 96 indexed citations
15.
Lin, Jin‐Shun, Yiwen Bu, Deliang Cao, et al.. (2012). Efficient synthesis of RITA and its analogues: derivation of analogues with improved antiproliferative activity via modulation of p53/miR-34a pathway. Organic & Biomolecular Chemistry. 10(48). 9734–9734. 17 indexed citations
16.
Liu, Ziwen, Ruilan Yan, Yi Shen, et al.. (2011). Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells. Biochemical Journal. 442(2). 273–282. 52 indexed citations
17.
Dong, Wei, Yingle Liu, Lü Chen, et al.. (2006). The IRAK-1-BCL10-MALT1-TRAF6-TAK1 Cascade Mediates Signaling to NF-κB from Toll-like Receptor 4. Journal of Biological Chemistry. 281(36). 26029–26040. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026